MedPath

SANDOZ EVEROLIMUS

SANDOZ EVEROLIMUS

Approved
DIN Number

02492911

Drug Class

Human

Market Date

Sep 17, 2020

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02492911
AIG Number0152682003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AH02 EVEROLIMUS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

EVEROLIMUSActive
Strength: 2.5 MG
Monograph: EVEROLIMUS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.